Literature DB >> 12037112

High variability between results of different in-house tests for cytomegalovirus (CMV) monitoring and a standardized quantitative plasma CMV PCR assay.

Lutz Von Müller1, Walter Hampl, Joachim Hinz, Helga Meisel, Angela Reip, Elisabeth Engelmann, Regine Heilbronn, Barbara Gärtner, Oliver Krämer, Hermann Einsele, Holger Hebart, Tatjana Ljubicic, Jürgen Löffler, Thomas Mertens.   

Abstract

A total of 2,718 blood samples were analyzed in five virological laboratories for the presence of cytomegalovirus (CMV) by in-house tests and one standardized plasma PCR assay. Results from in-house tests showed remarkable variability. Detection of CMV pp65 antigen or DNA from cells was more sensitive than that by plasma CMV PCR assay.

Mesh：

Substances：

Year:  2002        PMID： 12037112      PMCID： PMC130743          DOI： 10.1128/JCM.40.6.2285-2287.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

1.  Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma.

Authors:  A M Caliendo; R Schuurman; B Yen-Lieberman; S A Spector; J Andersen; R Manjiry; C Crumpacker; N S Lurain; A Erice
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

2.  Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation.

Authors:  V C Emery; C A Sabin; A V Cope; D Gor; A F Hassan-Walker; P D Griffiths
Journal:  Lancet       Date:  2000-06-10       Impact factor: 79.321

3.  The humoral immune response against human cytomegalovirus is characterized by a delayed synthesis of glycoprotein-specific antibodies.

Authors:  K Schoppel; B Kropff; C Schmidt; R Vornhagen; M Mach
Journal:  J Infect Dis       Date:  1997-03       Impact factor: 5.226

4.  Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture.

Authors:  M Boeckh; G M Gallez-Hawkins; D Myerson; J A Zaia; R A Bowden
Journal:  Transplantation       Date:  1997-07-15       Impact factor: 4.939

5.  Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation.

Authors:  M Sester; U Sester; B Gärtner; G Heine; M Girndt; N Mueller-Lantzsch; A Meyerhans; H Köhler
Journal:  Transplantation       Date:  2001-05-15       Impact factor: 4.939

6.  In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT.

Authors:  B Hertenstein; W Hampl; D Bunjes; M Wiesneth; C Duncker; U Koszinowski; H Heimpel; R Arnold; T Mertens
Journal:  Bone Marrow Transplant       Date:  1995-03       Impact factor: 5.483

7.  The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection.

Authors:  J M Grefte; B T van der Gun; S Schmolke; M van der Giessen; W J van Son; B Plachter; G Jahn; T H The
Journal:  J Gen Virol       Date:  1992-11       Impact factor: 3.891

8.  Human cytomegalovirus (HCMV) encephalitis in an immunocompetent young person and diagnostic reliability of HCMV DNA PCR using cerebrospinal fluid of nonimmunosuppressed patients.

Authors:  S Prösch; E Schielke; A Reip; H Meisel; H D Volk; K M Einhäupl; D H Krüger
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

9.  Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation.

Authors:  H Einsele; G Ehninger; H Hebart; K M Wittkowski; U Schuler; G Jahn; P Mackes; M Herter; T Klingebiel; J Löffler; S Wagner; C A Müller
Journal:  Blood       Date:  1995-10-01       Impact factor: 22.113

Review 10.  Quantitation of cytomegalovirus: methodologic aspects and clinical applications.

Authors:  M Boeckh; G Boivin
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132
  10 in total
  11 in total

1.  Monitoring of cytomegalovirus infection in solid-organ transplant recipients by an ultrasensitive plasma PCR assay.

Authors:  Karine Hadaya; Werner Wunderli; Christelle Deffernez; Pierre-Yves Martin; Gilles Mentha; Isabelle Binet; Luc Perrin; Laurent Kaiser
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

2.  Comparison of molecular tests for detection and quantification of cell-associated cytomegalovirus DNA.

Authors:  Angela M Caliendo; Belinda Yen-Lieberman; Jovana Baptista; Janet Andersen; Clyde Crumpacker; Rob Schuurman; Stephen A Spector; James Bremer; Nell S Lurain
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

3.  Evaluation of a new automated, standardized generic nucleic acid extraction method (total nucleic acid isolation kit) used in combination with cytomegalovirus DNA quantification by COBAS AMPLICOR CMV MONITOR.

Authors:  Barbara Christine Gärtner; Johannes Michael Fischinger; Anke Litwicki; Klaus Roemer; Nikolaus Mueller-Lantzsch
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

4.  Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in Korea.

Authors:  Su-Mi Choi; Dong-Gun Lee; Jung-Hyun Choi; Jin-Hong Yoo; Yoo-Jin Kim; Sun Hee Park; Chang-Ki Min; Seok Lee; Hee-Je Kim; Dong-Wook Kim; Jong-Wook Lee; Woo-Sung Min; Wan-Shik Shin; Chun-Choo Kim
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

5.  Comparison of the Digene Hybrid Capture System Cytomegalovirus (CMV) DNA (version 2.0), Roche CMV UL54 analyte-specific reagent, and QIAGEN RealArt CMV LightCycler PCR reagent tests using AcroMetrix OptiQuant CMV DNA quantification panels and specimens from allogeneic-stem-cell transplant recipients.

Authors:  Kimberly E Hanson; L Barth Reller; Joanne Kurtzberg; Mitchell Horwitz; Gwynn Long; Barbara D Alexander
Journal:  J Clin Microbiol       Date:  2007-02-21       Impact factor: 5.948

6.  Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients.

Authors:  Concepción Gimeno; Carlos Solano; José C Latorre; Juan C Hernández-Boluda; María A Clari; María J Remigia; Santiago Furió; Marisa Calabuig; Nuria Tormo; David Navarro
Journal:  J Clin Microbiol       Date:  2008-08-27       Impact factor: 5.948

7.  Active cytomegalovirus infection in patients with septic shock.

Authors:  Lutz von Müller; Anke Klemm; Manfred Weiss; Marion Schneider; Heide Suger-Wiedeck; Nilgün Durmus; Walter Hampl; Thomas Mertens
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883

8.  Detection of human cytomegalovirus DNA in various blood components after liver transplantation.

Authors:  X Y Chen; P F Hou; J Bi; C M Ying
Journal:  Braz J Med Biol Res       Date:  2014-04-08       Impact factor: 2.590

9.  Comparison of quantitation of cytomegalovirus DNA by real-time PCR in whole blood with the cytomegalovirus antigenemia assay.

Authors:  Seonhee Kwon; Bo Kyeung Jung; Sun-Young Ko; Chang Kyu Lee; Yunjung Cho
Journal:  Ann Lab Med       Date:  2014-12-08       Impact factor: 3.464

10.  Detection of Cytomegalovirus (CMV) Infection in Wheezing Infants by Urine DNA and Serum IgG Testing.

Authors:  Zhao-Cheng Zeng; Qing Chang; Zhi-Wei Sun; Ming-Mei Song; Xin-Ling Jin; Shu-Ya Jiang; Xia Yang
Journal:  Med Sci Monit       Date:  2017-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.